Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

rAd/p21: an effective gene therapy approach for treating lung cancer

Sep. 15, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

FDA recommends full approval of first new treatment for metastatic colorectal cancer in 40 years

Sep. 11, 1998

DDE-131: new apoptosis-inducing antitumor agent from WHI

Sep. 11, 1998

Natural nonpeptide inhibitors of protein farnesyltransferase discovered at Merck & Co.

Sep. 10, 1998

Novel antitumor macrocyclic lactones available for licensing from NIH

Sep. 9, 1998

WHI investigators design novel inhibitors of EGF receptor tyrosine kinase

Sep. 9, 1998

Canadian academic researchers identify estrone sulfatase inhibitors

Sep. 8, 1998

Purlytin enters development for prostate cancer; another cancer indication abandoned

Sep. 8, 1998

FDA indicates approvability of DepoCyt for neoplastic meningitis from lymphomas

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...